Benchmark Holdings PLC (LSE:BMK) - Share price - Overview

Stock Report

Benchmark Holdings PLC BMK

Last Price
GBX59.50

Day Change
0.50|0.85%

As of 27/07/2017
15:51:17 BST | GBX
Minimum 15 Minutes Delay.

Last Close59.00p
Day Range58.10 - 59.90
Mkt Cap308.10Mil
52-Wk Range56.00 - 111.50
Yield %0.00
ISINGB00BGHPT808
Volume35,749
P/E-64.32
P/S2.27
P/CF-19.49

Share Price

Total Returns 26/07/2017

 Chg (%)  
More ...
Benchmark Holdings PLC-20.78 
FTSE 100 TR GBP0.12
 
Financials
201420152016
More ...
Income Statement
Turnover35.3544.20109.38
Operating Profit-1.19-11.60-20.47
Net Profit-1.32-11.76-18.35
Reported EPS-1.04-5.96-4.39
Balance Sheet
Current Assets32.5839.22102.49
Non Current Assets15.9394.85408.42
Total Assets48.50134.07510.91
Current Liabilities9.5226.3233.71
Total Liabilities11.2541.97143.21
Total Equity37.2592.10367.70
Cash Flow
Operating Cash Flow0.28-8.85-9.10
Net Change in Cash14.77-2.9524.58
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20170.960.68-86.64---
20187.401.3699.2743.480.44--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
26/04/2017PurchaseThe Hon Alex Hambro90.0053,12547,813.00
13/03/2017Exercise of OptionMr. Mark Plampin0.1056,93857.00
15/02/2017PurchaseKevin Quinn94.0425,00023,510.00
01/12/2016Exercise of OptionMr. Mark Plampin10.00135,00013,500.00

Company Profile

Benchmark Holdings PLC is engaged in the development, manufacture and commercialisation of animal health vaccines, medicines, biocides and diagnostics with a focus on aquaculture.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

585 of 1846 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(27/06/2017) "...we look forward to the future of the blue revolution with great confidence"

Next Event 30/09/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)47.7814.5316.61
Div Yld (E)0.003.804.14
PEG (E)0.220.521.01
ROCE-5.78191.4513.38
Op Mrgn-6.62-5.404.56
EPS Grwth216.0535.1630.94
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanThe Hon Alex Hambro
Chief Executive OfficerMr. Malcolm Pye
Chief Financial OfficerMr. Mark Plampin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.